Zoic Capital

Zoic Capital is a Seattle-based venture capital firm that invests in early-stage companies applying hard science and frontier technologies, supported by strong intellectual property, to defined global challenges. Its sector focus is concentrated in life sciences and medical technology, with intellectual property strategy treated as a core element of how portfolio companies are built and evaluated.

Investment activity covers the first three rounds of capital - seed through Series A - with the stated aim of developing science-based businesses into commercial ventures. Beyond capital, the firm works with portfolio companies on strategic and operational development, intellectual property strategy, and on establishing potential relationships with strategic acquirers, indicating a hands-on model of involvement in company formation and exit positioning.

A third strand of the firm's activity is a co-investment program, which gives institutions, family offices, registered investment advisers, and high-net-worth individuals access to venture and venture-adjacent opportunities that Zoic underwrites and manages. For candidates, the firm's emphasis is on frontier technology with defensible IP, clearly defined problems, and close engagement with founding teams rather than passive capital provision.